Novartis gets U.S. approval for bigger dose Glatopa MS treatment

ZURICH (Reuters) - Novartis's Sandoz division said on Tuesday it has won approval in the United States for a larger dosage of its Glatopa treatment for multiple sclerosis patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news